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Abstract
Sirenomelia is a very rare limb anomaly in which the normally paired lower limbs are replaced by 
a single midline limb. This study describes the prevalence, associated malformations, and maternal 
characteristics among cases with sirenomelia. Data originated from 19 birth defect surveillance 
system members of the International Clearinghouse for Birth Defects Surveillance and Research, 
and were reported according to a single pre-established protocol. Cases were clinically evaluated 
locally and reviewed centrally. A total of 249 cases with sirenomelia were identified among 
25,290,172 births, for a prevalence of 0.98 per 100,000, with higher prevalence in the Mexican 
registry. An increase of sirenomelia prevalence with maternal age less than 20 years was 
statistically significant. The proportion of twinning was 9%, higher than the 1% expected. Sex was 
ambiguous in 47% of cases, and no different from expectation in the rest. The proportion of cases 
born alive, premature, and weighting less than 2,500 g were 47%, 71.2%, and 88.2%, respectively. 
Half of the cases with sirenomelia also presented with genital, large bowel, and urinary defects. 
About 10–15% of the cases had lower spinal column defects, single or anomalous umbilical 
artery, upper limb, cardiac, and central nervous system defects. There was a greater than expected 
association of sirenomelia with other very rare defects such as bladder exstrophy, cyclopia/
holoprosencephaly, and acardia-acephalus. The application of the new biological network analysis 
approach, including molecular results, to these associated very rare diseases is suggested for future 
studies.
Keywords
sirenomelia; caudal regression spectrum; twinning; maternal age; world prevalence; caudal 
dysgenesis
INTRODUCTION
According to Stevenson [2006] “Sirenomelia is a limb anomaly in which the normally 
paired lower limbs are replaced by a single midline limb.” This is probably the best 
definition in the literature because it does not use the term “fusion.” Other definitions 
characterize sirenomelia as different degrees of fusion between the lower limbs. However, 
the term “fusion,” derived from Latin fundere, should be avoided because, as a noun derived 
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from Latin fundere, it implies the uniting of separated parts, in this case the para-medial 
limb buds, which is an unproven mechanism of production for sirenomelia.
Definition and Diagnostic Challenges
Even when sirenomelia seems to be a discrete and well-defined anomaly, some difficulties 
can be encountered in its delineation. On one hand, if its definition as the presence of an 
axial positioned single lower limb is accepted, the first three of the seven types in Stocker 
and Heifetz [1987] classification (see next section on Classification) cannot be included as 
sirenomelias since they do not present an axial single lower limb. On the other hand, 
extended crural or multiple crural-popliteal-talus pterygia can overlap with Type-I sire-
nomelia from the clinical and radiological standpoints. Furthermore, when associated with 
other unrelated anomalies such as craniofacial, sirenomelia may overlap with multiple 
pterygium syndromes of the Bartsocas–Papas [Bartsocas and Papas, 1972], or Aslan type 
[Aslan et al., 2000], OMIM 263650 and 605203, respectively. However, popliteal pterygia 
associated with caudal regression spectrum (CRS; caudal dysgenesis) were described in a 
child born from a diabetic mother [Al Kaissi et al., 2008].
ICD-10 lacks a specific code for sirenomelia, which must be coded as Q87.2 “congenital 
malformation syndromes predominantly affecting limbs.” This is a serious limitation for the 
study of time-space clusters, as reported from South America [Castilla et al., 2008; Orioli et 
al., 2009], as well as for statutory birth defects registries that only use ICD-10 as the basis 
for their coding system for congenital anomalies. The pediatric extension of ICD10 (BPA) 
has a specific code for “sirenomelia syndrome” which is Q87.24.
Prenatal diagnosis of sirenomelia by ultrasound is impaired by the coexisting 
oligohydramnion resulting from the frequently associated bilateral renal a/dysgenesis 
[Wasnik and Lalchandani, 2010]. However, there is a narrow window, between weeks 8 and 
16 of gestation, that is, when the limb structures are visible to ultrasound, and the amniotic 
fluid still depends mainly from maternal production, when visualization of sirenomelia is 
possible [Valenzano et al., 1999; Schiesser et al., 2003]. Nevertheless, first trimester 
ultrasono-graphic examinations are infrequent and only a few cases of early diagnosed 
sirenomelia have been reported [Blaicher et al., 2001; Carbillon et al., 2001; Akbayir et al., 
2008]. Patel and Suchet [2004] applied color and power Doppler ultrasound to diagnose 
second and third trimester fetuses with sirenomelia mainly based on fetal vascular images.
Classification
Sirenomelia was first classified into three types according to the number of feet and named 
sympus apus, monopus, and dipus, for none, one, or two feet, respectively [Foerster, 1861–
1865]. A more adequate classification of sirenomelia is that of Stocker and Heifetz [1987] in 
which seven types are defined: I, all thigh and leg bones present; II, single fibula; III, absent 
fibulae; IV, partially fused femurs, fused fibulae; V, partially fused femurs, absent fibulae; 
VI, single femur, single tibia; VII, single femur, absent tibiae. However, none of these 
classifications follow a dysmorphogenetic rationale, proposing nothing more than discrete 
groupings of a continuous spectrum.
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Historical Aspects
Very rare congenital defects (VRDs), having an expected occurrence rate of 1 per 100,000 
or lower, were expected to happen only once every several generations in most ancient 
populations at the time of polytheist religions, when several VRDs became mythological 
figures. Early human populations were mostly rural, and urban areas seldom passed over 
1,000 inhabitants, except for classical Athens, one of the first known city-state, with about 
100,000 residents in the late 5th and 4th century BC [Scheidel, 2008]. Thus, even with a 
natality rate as high as 50 per thousand per year, no more than one case of a given VRD 
every 20 years or more was to be expected (i.e., approximately one case per generation, 
assuming 25 years per generation). Pictured or written descriptions probably facilitated the 
recording and/or historical recognition of a given VRD. Nevertheless, the large time-lapse 
between occurrences in ancient populations probably allowed for magical or mythological 
thinking about such defects [Stahl and Tourame, 2010].
Sirenomelia, cyclopia, and, to a lesser degree, conjoined twins received special attention in 
most fantasies, mythologies, and religions, in which these defects seem to have been taken 
more as caprice of nature than as real monstrosities. Sirenomelia is referred as “mermaid” in 
mythology, that is: as a female, more frequently than as the male counterpart “merman,” or 
Triton type sirenomelia, probably due to the more attractive and esthetic sensual attributes, 
as bosom, eyes, and hair in the female gender when external genitalia was omitted.
Embryology
Normal development: Morphology—In the mouse, each lower limb derives from a 
different para-medial developmental field determined at gastrulation due to the expression of 
Pitx1-dependent Tbx4 [Ouimette et al., 2010]. This process occurs over 25 days, beginning 
at week 4 after fertilization, and by the end of the eighth week, the limb is perfectly formed. 
Lower limbs are delayed 2 days in comparison to forelimbs. The trigger for limb bud 
initiation is unknown, even though fibroblast growth factors 8 and 10 are hypothesized as 
being involved [Agarwal et al., 2003].
Limb development is a continuous process that encompasses meso- and ectodermal 
components and is divided into four stages: the bud (outgrowth), the paddle (dorso-ventral 
flattening), the plate (relative expansion of the distal end), and the rotation (around the 
proximo-distal axis). In the latter stage, the position of the limb buds relative to the trunk 
change due to the differentiate growth of the cartilage model that continues to elongate the 
limb, with different parts growing at different rates. Lower limbs twist around their 
proximo-distal axis medially (internally) bringing the great toe to the midline from its initial 
postaxial position [Larsen, 1993].
Abnormal development: Dysmorphology—Two main non-mutually exclusive 
hypotheses were advanced to explain the abnormal development of the lower limbs leading 
to sirenomelia: blastogenetic and vascular. The former hypothesis postulates a primary 
anomaly in the development of the caudal axial mesoderm [Källén and Winberg, 1974; 
Opitz et al., 2002; Kjaer et al., 2003; Garrido-Allepuz et al., 2011], while the latter is based 
on an abnormal development of the umbilical vessels resulting in a deficient blood supply of 
ORIOLI et al. Page 4
Am J Med Genet C Semin Med Genet. Author manuscript; available in PMC 2015 July 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
the caudal part of the embryo [Kampmeier, 1927; Hentschel et al., 2006]. This latter 
hypothesis is supported by observations of caudal “vascular steal” through a persistent 
vitelline artery [Stevenson et al., 1986; Bianchi et al., 2000; Patel and Suchet, 2004]. There 
have been several case reports supporting the vascular hypothesis [Hentschel et al., 2006; 
Duesterhoeft et al., 2007] as well as some rejecting it [Jaiyesimi et al., 1998]. Since these 
hypotheses are extended to the whole CRS, as well as to other associated defects, it is 
feasible that both hypotheses are valid, even allowing for additional possible pathogenetic 
mechanisms to be proposed in the future.
Sirenomelia and caudal regression spectrum (CRS)—The concept of sirenomelia 
as the most severe extreme of CRS was advanced by Duhamel [1961], fitting within the 
general concept of very rare defects being extremes of dysmorphologic spectra [Castilla and 
Mastroiacovo, 2011]. While sirenomelia and CRS without sirenomelic share some common 
characteristics as male sex preference, maternal diabetes, and absent sacrum [Duesterhoeft et 
al., 2007], associated defects as single umbilical artery, lethal renal a/dysgenesis, and 
oligohydramnios-related deformities are much more frequent in the former than in the latter 
[Källén and Winberg, 1974; Martínez-Frías et al., 2008]. Thus, the concept of sirenomelia 
and caudal dysgenesis being at the severest end of the same CRS, proposed by Thottungal et 
al. [2010] makes sense and incorporates most observations made until now [Goodlow et al., 
1988; Guidera et al., 1991; Das et al., 2002].
Genetics and Clinical Genetics
As is the case with most, if not all congenital anomalies, sirenomelia is etiologically 
heterogeneous. No instances of familial recurrence of sirenomelia have been reported. 
However, under the pathogenetic concept of sirenomelia as part of the CRS, familial cases 
are known. A pair of sirenomelic concordant identical twins was reported by Di Lorenzo et 
al. [1991]. Four siblings with renal defects, one of them with sirenomelia [Selig et al., 1993], 
are considered to have renal adysplasia (OMIM 191830), The renal adysplasia patients can 
have mutations in the RET gene (OMIM 164761) located at 10q11.2 or in the uroplakin IIIA 
gene (UPK3A; OMIM 611559) located at 22q13.31. Sirenomelia was reported in one case 
with an extra small bisatellited marker chromosome identified as the proximal part of the 
long arm of chromosome 22 [Jensen and Hansen, 1981]; probably this case was an earlier 
example of UPK3A gene deletion.
Molecular studies in CRS show a variety of specific anomalies: mutations in the VANGL1 
gene mapped at 1p13 for CRS [Kibar et al., 2007], a homeo-box gene on chromosome 7q36 
for anorectal atresia [Lowry et al., 2007], and mutations in HLXB9 gene for the Currarino 
syndrome reported by Köchling et al. [2001]. No gene mutations have been reported in 
sirenomelia patients. No SHH mutations were found by Vargas et al. [1998] in sacral 
agenesis/sirenomelia cases. Sirenomelia can occur in crosses between specific mice strains 
and as consequence of mutations that increase retinoic acid, as observed in gene-knockouts 
of Cyp26 that codifies for a retinoic acid degrading enzyme (CYP26), recently revised by 
Pennimpede et al. [2010].
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Zakin et al. [2005] have shown that the lack of bone morphogenetic protein 7 (Bmp 7) in 
combination with half a dose or complete loss of twisted gastrulation (Tsg) protein cause 
sirenomelia in mice. Tsg is one of several regulators of Bmp, whose gradient determines the 
dorso-vertebral patterning in vertebrate and invertebrate embryos. The same team has earlier 
described that in the absence of Tsg, the loss of one copy of Bmp4 results in 
holoprosencephaly and branchial arc defects [Zakin and De Robertis, 2004]. Then, Tsg and 
Bmp interaction seems doubly interesting to the VRD studies, considering the occurrence of 
both conditions, sirenomelia and holoprosencephaly, in the same human newborn [Martínez-
Frías et al., 1998b].
A so-called “mermaid (merm) mutant” (Nup133merm mutation) was described disrupting 
mouse (mus musculus) gastrulation which is a functional null allele of nucleoporin Nup133, 
a constituent of the conserved Nup107-160 complex [García-García et al., 2005]. The 
phenotype in mice includes exencephaly, shortened trunk, irregularly segmented somites, 
and a minimal tail bud.
Epidemiology: Prevalence, Risk Factors
Prevalence—The birth prevalence of sirenomelia varies from 1 to 2 per 100,000, 
depending on the denominator definition and case ascertainment since one-third of the cases 
of sirenomelia are stillborn [Källén et al., 1992; Castilla and Orioli, 2004]. From 10% to 
15% of occurrences are in twin births, mostly monozygous [Valenzano et al., 1999].
Due to the absence of external genitalia and infrequent information on gonadal or 
chromosomal sex, data on sex distribution are very scarce. Nonetheless, the limited 
information available indicates male sex preference [Duesterhoeft et al., 2007], or does not 
indicate any substantial sex preference [Källén et al., 1992].
Clusters—A time-space cluster of sirenomelia in 2005 in the city of Cali (Colombia) was 
reported by ECLAMC (Spanish acronym for the Latin American Collaborative Study of 
Congenital Malformations) [Castilla et al., 2008; Orioli et al., 2009]. As with most reported 
epidemics of congenital anomalies, except for phocomelia due to maternal thalidomide 
exposure this cluster ended spontaneously, without identification of its cause. The most 
interesting aspect of this cluster is the nearly simultaneous rise and fall in the birth 
prevalence rates of sirenomelia and cyclopia, supporting the concept of shared causal 
factors.
Maternal age—An international study showed an U-shaped curve with increased risk for 
sirenomelia at young and old maternal ages: under 20, and over 40 years old [Källén et al., 
1992]. However this observation has not been investigated further.
Maternal diabetes—One-fifth of published sirenomelia cases were delivered to diabetic 
mothers, the offspring of whom are reported to have a prevalence of one in 200 births for a 
sirenomelia/caudal regression (CRS) infant [Gurakan et al., 1996; Martínez-Frías et al., 
1998a; Al-Haggar et al., 2010]. However, in a 15-year pathology series Bruce et al. [2009] 
found a history of maternal diabetes in three out of nine CRS cases, but in none of six cases 
of sirenomelia.
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Some associations with sirenomelia and/or CRS such as VATER association [Castori et al., 
2010], pterygia [Al Kaissi et al., 2008], and twinning [Zaw and Stone, 2002] present with a 
history of maternal diabetes providing clues for a common risk factor. Castori et al. [2010] 
report a diabetic mother having had infants with sirenomelia and VATER association from 
two out of her three pregnancies, indicating a possible causal relationship between maternal 
diabetes and these two early blastogenic defects. Beside this observation, these authors also 
speculate on the pathogenetic identity of both anomalies belonging to the same 
dysmorphogenic spectrum. These conclusions were based not only on the reported case but 
also on two previously published observations [Valenzano et al., 1999; Castori et al., 2008].
Environmental risk factors—Several chemicals have been reported to induce 
sirenomelia/CRS in experimental mammals, including retinoic acid in mice [Padmanabhan, 
1998], cadmium and lead in golden hamsters [Hilbelink and Kaplan, 1986], and ochratoxin 
A in chick embryos [Wei and Sulik, 1996]. Human reports on prenatal exposures include 
cocaine [Sarpong and Headings, 1992], and an undefined “snuff” [Taghavi et al., 2009]. A 
thorough review by Holmes [2002] found no plausible teratogens associated with 
sirenomelia.
Associated and Combined Anomalies
Since sirenomelia is not well delineated, relative to the CRS, it is difficult to specify which 
congenital anomalies are pathogenetically associated with sirenomelia. Association of 
sirenomelia/CRS with component anomalies of the Potter sequence is obviously expected 
due to the an/oligohydramnios produced by the usually associated severe and lethal renal a/
dysgenesis [Savader et al., 1989; Al-Haggar et al., 2010]. An association between 
sirenomelia/CRS and VATER association could be explained by both deriving from an early 
blastogenic insult, when the potential embryo exists in a single developmental field [Opitz et 
al., 2002]. Epidemiological data supporting this were provided by Duncan and Shapiro 
[1993], Duncan et al. [1991], and Schüler and Salzano [1994]. Further support came from 
clinical observations, in which maternal diabetes provided an etiological ground for both 
anomalies [Kalter, 1993; Valenzano et al., 1999; Castori et al., 2010], as well as from more 
recent experimental studies with adriamycin in rats and mice [Abu-Hijleh et al., 2000; 
Dawrant et al., 2007]. The alternative approach of searching for sirenomelia/CRS in 
association with VATER in the same patient also provided support to this preferential 
association [Botto et al., 1997; Rittler et al., 1996].
Another potential similarity of sirenomelia/CRS with VATER association is imperforate 
anus, the A in VATER acronym, which Duhamel [1961] proposed as the mildest end of the 
CRS. However, during the survey of the epidemic of sirenomelia in the city of Cali, 
variations in the birth prevalence of imperforate anus was analyzed as a sentinel phenotype 
for minor forms of CRS, and no concomitant rise in frequency was detected [Castilla et al., 
2008].
The reported association of sirenomelia/CRS with neural tube defects (NTD), mainly with 
spina bifida, is to be expected since the lower spine is affected in this anomaly [Källén et al., 
1992]. A more extended NTD in a fetus with sirenomelia and acardia was reported by 
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Halder et al. [2001]. Sirenomelia and popliteal or multiple pterygia were reported in some 
cases [Aslan et al., 2000], and a common causality due to maternal diabetes was proposed 
[Al Kaissi et al., 2008].
Combined VRD—We are here naming as “combined” VRD the concurrence of two or 
more of the eight defects (acardia, amelia, phocomelia, conjoined twins, cyclopia, 
sirenomelia, bladder, and cloaca esxtrophies) reported in this series of articles with material 
from ICBDSR [2009]. This is to distinguish them from the commonly named “associated” 
for the coexistence of sirenomelia with other unrelated congenital anomalies. The occasional 
coincidence of more than one VRD in the same individual is difficult to accept as chance 
occurrence, and a common etiopathogenic mechanism is more likely to explain it since most 
of them are presumably early blastogenic defects [Opitz et al., 2002].
Sirenomelia–Cyclopia—There is evidence for concurrence of sirenomelia and cyclopia 
in the same patient [Martínez-Frías et al., 1998b], being associated with similar 
epidemiological risk factors [Källén et al., 1992]; being observed in the same clusters 
[Castilla et al., 2008], and for potentially sharing a similar pathogenetic mechanisms 
[O’Railly and Müller, 1989].
Sirenomelia–Acardia—Concurrence in the same case was documented by Zanforlin 
Filho et al. [2007], as well as by Halder et al. [2001].
Sirenomelia/CRS and situs inversus in the same case were reported by Langer et al. [1999] 
and Rougemont et al. [2008].
Prognosis, Treatment, Survival, and Prevention
Except for very rare instances, sirenomelia is a lethal condition in the perinatal period, 
hampering any intent of treatment. In a large set of consecutive birth series (10.1 million 
births), 97 cases of sirenomelia were identified, 35 of them in stillbirths, and 62 in live births 
who died shortly after birth [Källén et al., 1992].
In sirenomelia, the prognosis for morbidity, survival, and quality of life depends almost 
exclusively on the presence or not of congenital anomalies affecting vital organs, such as 
renal a/dysgenesis [Messineo et al., 2006]. There is documentation of one individual with 
sirenomelia born in the early 1990s that was claimed to be the second surviving case of 
sirenomelia known [Murphy et al., 1992], additionally, there is documentation in 2003 of a 
4-year-old patient reported to be the fifth surviving patient [Stanton et al., 2003].
Only about 1% of cases survive the first week of life. Among these, three cases with Stocker 
and Heifetz [1987] types I to III of sirenomelia were widely publicized through the lay 
press. One of them was born in August 1999 in Kennebunkport, Maine, USA, having a 
small remnant of a kidney, 15 cm of large intestine, one ovary, and absent uterus and 
external genitalia. She underwent two kidney transplants, dying at the age of 10 years from 
pneumonia. The other two cases still are still alive at present (in 2011), both of them, 
apparently having no other major anomalies, and who underwent successful surgery for leg 
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separation. However, as mentioned above, these milder types could not be true sirenomelias, 
but pterygia involving just the soft tissues of lower limbs.
There is room for the primary prevention of sirenomelia through the appropriate pre-
conceptional diagnosis and treatment of all types of diabetes that can lead to an exposure of 
the early embryo to high levels of maternal glycemia. In theory, as many as 20% of all cases 
of sirenomelia could be avoided [Kadian et al., 2008; Delissaint and McKyer, 2011].
In order to expand on the limited epidemiologic information on sirenomelia, we conducted a 
descriptive analysis of prevalence data collected on sirenomelia by 19 program members of 
the International Clearinghouse for Birth Defects Surveillance and Research (hereafter 
referred to as “the Clearing-house”). In this analysis, we examined the variation in 
prevalence by program, over time, and by selected maternal and infant characteristics.
METHODS
The Clearinghouse collects data from 46 member birth defect surveillance programs around 
the world, sampling out data from 37 countries. Six countries have two or more participating 
programs, and one (ECLAMC: Estudo Colaborativo Latino Americano de Malformações 
Congênitas) including hospitals from 10 different South American countries. Each program 
submits data in the same format to the Clearinghouse for the annual report, which includes 
detailed descriptions of each member registry [ICBDSR, 2009].
Study Design and Cohorts
This was a retrospective cohort study from population-based and hospital-based birth defect 
surveillance programs. Nineteen programs from North and South America, Europe, China, 
and Australia provided data on sirenomelia, ascertained from a total birth population of 
almost 25.3 million births. Birth years included in the study ranged from 1968 to 2006, and 
varied by program. Births included live births, stillbirths, and, for some but not all programs, 
elective pregnancy terminations for fetal anomalies (ETOPFA).
Cases with sirenomelia were classified according to the number of defects unrelated to the 
CRS [Orioli et al., 2009]. Defects considered as related to sirenomelia include urinary, 
genital, large bowel, low spinal column, single umbilical artery, and oligohydramnion 
derived defects. Other types of defects were grouped into 17 sets: other spinal column or rib, 
small intestine, esophagus or diaphragmatic, cardiac, upper limb, abdominal or thoracic 
wall, ear, eye, oral cleft, other facial, holoprosencephaly, skin tag, situs inversus, 
hydrocephalus, CNS, other artery, and other defects; and each of them subdivided into 
different sub-sets under different ad hoc codes. The cases with sirenomelia were also 
separated into isolated cases (i.e., cases with no other defect outside the sirenomelia 
spectrum reported in the same case); and MCA (multiple congenital anomalies) cases (i.e., 
cases with associated non-sirenomelia-spectrum defects reported).
Programs were asked to provide de-identified case records following a common protocol, 
with information on phenotype, genetic testing, and selected demographic and prenatal 
information. Further details can be found in Castilla and Mastroiacovo [2011] in this issue.
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Case Review
All records were reviewed by two experienced dysmorphologists (PM, IMO). When 
information was unclear or missing, clarification and further data were requested from the 
participating program. All cases were reported verbatim and centrally classified.
Inclusions and Exclusions
Included were cases of sirenomelia, as identified by the participating programs. Cases with 
extended crural pterygium, and non-medial single lower limb, suggestive of lower limb 
amelia were excluded. Spontaneous abortions (less 500 g, or 20 weeks gestation) were 
excluded among cases and denominators.
Statistical Methods
Occurrence was expressed as total prevalence (number of live births, stillbirths and 
ETOPFA with sirenomelia per 100,000 births) with its 95% confidence intervals (CI). For 
each program the expected number of cases was calculated under the hypothesis of a 
homogeneous prevalence among all programs. Using the expected values, we calculated the 
exact Poisson probabilities of observing N or more cases (P (N ≥X)) in each registry. 
Maternal age-specific prevalence ratios were calculated using the number of total cases and 
all births (live births and stillbirths) data by 5 years maternal age groups and using the 25–29 
years group as the reference group. Pearson correlation was used as a measure of correlation 
between the prevalence of sirenomelia and two variables: the number of births and the 
proportion of ETOPFA in each registry. The 95% CI were computed using the Poisson 
distribution. Statistical test significance was set to P <0.05. Statistical analyses were done 
with Stata software, version 10.0 [StataCorp, 2007].
RESULTS
Prevalence
The total number of births and of sirenomelia cases is given in Table I for each of the 19 
surveillance programs members of the International Clearing-house for Birth Defects 
Surveillance and Research (ICBDSR). A total of 249 cases with sirenomelia were identified 
among 25,290,172 births, for a birth prevalence of 1 per 100,758 births or 0.98 per 100,000 
(95% CI 0.87–1.11). The proportion of ETOPFA was 24.5% considering all reported cases. 
ETOPFA was not permitted in two surveillance programs (Mexico RYVEMCE: Registro y 
Vigilancia Epidemiológica de Malformaciones Congénitas; and South America ECLAMC), 
and was not recorded in another two (Spain ECEMC: Spanish Collaborative Study of 
Congenital Malformations; and China, Beijing). Excluding these four programs the 
proportion of ETOPFA was 49.5%. There was no correlation between the proportion of 
cases of sirenomelia submitted to ETOPFA and the sirenomelia prevalence (r =0.25; P 
=0.37).
Figure 1 shows the sirenomelia prevalence with their 95% CI in the different surveillance 
programs. Hungary (0.33 per 100,000; 95% CI 0.16–0.61; P <0.0001) as well as Italy 
Campania (0.16 per 100,000; 95% CI 0.00–0.87; P <0.013) show statistically significant 
lower prevalence, suggesting under-ascertainment. Five programs show a statistically 
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significant higher sirenomelia prevalence: Mexico RYVEMCE: 2.36 (95% CI 1.53–3.49; P 
<0.0001), South America ECLAMC: 1.36 (95% CI 1.04–1.74; P <0.006), Italy North-East 
1.69 (95% CI 1.03–2.60; P <0.009), Canada Alberta (1.6 per 100,000; 95% CI 0.93–2.56; P 
< 0.021), and Wales (2.25 per 100,000; 95% CI 0.73–5.25; P <0.024). If we discard the two 
registries with under-ascertainment only the Mexican registry had a higher prevalence than 
the other registries.
There was no correlation between the sirenomelia prevalence and number of births in each 
surveillance program (r =0.03; P =0.92). More than half (53.4%) of the sirenomelia cases in 
this study were provided by four reporting surveillance programs: South America 
ECLAMC, France Central East, Mexico RYVEMCE, and Italy North East.
Secular Variation
There is variation in the annual frequencies of sirenomelia within each of the 19 programs. 
However, there were no evident secular trends.
Maternal Age
For the maternal age analyses we excluded sirenomelia cases and births from China (before 
1997 and after 2003), Italy North-East, and Italy Sicily because the number of births by 
maternal age was not available. Maternal age was analyzed in six groups: less than 20 years, 
20–24, 25–29, 30–34, 35–39, and 40 years or older. In Table II the sirenomelia prevalence 
for each maternal age group and the prevalence ratios for maternal age groups relative to the 
reference age group of 25–29 years with corresponding 95% CI are shown. There was a 
clear gradient (Fig. 2) in the sirenomelia prevalence from younger to older maternal age 
groups (P <0.01), with the prevalence ratio for maternal age less than 20 years increased 
significantly (1.71; 95% CI 1.13–2.59). When the cases were separated into isolated or 
MCA (multiple congenital anomalies) groups (Table III), the same prevalence trend and 
significant prevalence ratio remained only for the MCA group.
Sex
The sirenomelia spectrum of defects includes external and internal genital defects; thus 
making sex determination difficult. Autopsy findings were more helpful in the sex 
determination since only 12 patients (8 females and 4 males) had a karyotype result. In 11% 
of cases the sex was unknown and 47.0% were described as having ambiguous genitalia. 
The proportion of males (49%) did not differ from the 51% expected in the sample of 105 
patients with determined sex. When grouping patients into isolated and associated defects, 
the proportion of unspecified sex was smaller in the MCA (7.1%) than in the isolated group 
(14.6%). The ETOPFA cases had 47% of males among the small sample of 43 patients with 
determined sex; information on sex was missing in only 3%, and not determined in 18%.
Other Risk Factors
Information on risk factors (i.e., mainly maternal exposures during pregnancy) was not 
available for most of the registries. Among 133 informative cases, there were seven (5%) 
with maternal diabetes. Misoprostol first trimester exposure was found in one case, and 
fever in six cases (4.5%).
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None of the 249 sirenomelia cases had any indication of other family members being 
affected by this or CRS.
Descriptive Analysis of Sirenomelia Patients
There were 123 isolated cases (49%), and 126 (51%) with other non-related defects. In 
Table IV we present the comparison of sex, outcome, birth weight, gestational age, parity, 
previous spontaneous abortion, plurality, maternal age, parental age difference, and maternal 
education between isolated and MCA sirenomelia cases. The associations with maternal age 
and sex were already described above. Pregnancy outcomes among sirenomelia cases were: 
liveborn 47%, stillbirths 28.5%, and ETOPFA 24.5%. The proportion of ETOPFA was 
slightly higher in MCA cases (28.6%) than in the isolated cases (20.3%), but the difference 
did not reach statistical significance (P =0.13). For other pregnancy outcomes, the isolated 
and MCA cases had similar distributions.
Only 11.1% of the sirenomelia births weighed more than 2,500 g. The proportion of cases 
who were low birth weight did not differ between isolated and MCA cases. Prematurity was 
found in 71.2% of the cases, with 25.6% below 32 weeks, and 37.6% between 33 and 36 
weeks of gestation, and no difference between isolated and MCA cases. The proportions of 
first births, previous spontaneous abortion, years of parental age difference and of maternal 
education did not differ between the isolated and MCA groups of sirenomelia cases, and 
were similar to those expected in the general population. However, the proportion of 
multiple births among sirenomelia cases was 8% versus an expected rate of 1% or slightly 
more in the general population.
Related and Unrelated Defects in Sirenomelia
Single midline lower limb, reno-urinary, genital, large bowel, low spinal column, single or 
anomalous umbilical artery, and oligohydramnios-derived defects were in this work 
considered as part of the sirenomelia sequence. Cases with sirenomelia that had other 
different defects were classified as MCA cases. Cases with inadequately described or minor 
defects were not considered. The isolated group (I) comprised of 123 infants (49%), and the 
remaining 126 (51%) were divided in groups having 1 (28%), 2 (16%), and 3 or more 
unrelated defects (7%), The unrelated defects formed 17 groups of defects coded ad hoc as 
explained in the Methods Section. Since the description of the specific defects is higher in 
MCA groups with 812 specific defects described in 126 patients (6.44 defects by patient) 
than in the isolated group with 346 specific defects in 123 patients (2.81 defects by patient), 
we show the frequency of related defects only in MCA group or in the total sample.
Related Reno-Urinary Defects
Urinary defects were mentioned in 57.1% of MCA cases and in 46.6% of all cases. Total 
absence of the reno-urinary tree was described in 73.3% of informative cases. Unilateral 
kidney agenesis or bilateral hypoplasia was seen in 9.5%, cystic or dysplastic kidneys in 
12.9%, horseshoe kidney (including horseshoe cystic kidney) in 5.2%, and hydronephrosis 
in 4.3% of the cases.
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Related Genital Defects
Genital defects were described in 59.5% of MCA and in 57% of all patients. Absence of 
total genitalia absence was reported in 59.9%, and ambiguous genitalia in 25.4% of all 142 
informative patients.
Related Lower Spinal Column Defects
Most of the sirenomelia cases (80.2% in MCA groups) had no lower spinal column defects 
described, with this defect being present in 16% of all cases. Sacral or sacrococcygeal 
absence was present in 59.9% of the 40 informative cases, and the sacral or sacrococcygeal 
defects described in 25.4% of these cases.
Related Large Bowel Defects
Defects of the large intestine were described in 62.7% of MCA cases, being present in 
53.4% of all cases. Anal atresia was the most frequent defect, present in 91.0% of 133 
informative cases. Anal and intestinal duplication were described in three cases.
Other Related Defects
Single or anomalous umbilical artery was present in 16.5% and oligohydramnion related 
defects in 24.9% of all cases. Among the 62 cases with these defects, 12.4% were described 
as Potter anomalies and 7.2% as lung hypoplasia.
Unrelated Defects
The 17 groups of unrelated defects observed in the 126 MCA sirenomelia patients were 
defined in the Methods Section. Below they are summarized in the limb, trunk, and head 
regions.
Limbs
The commonest non-related defects (30.2%) among the MCA group were those in the upper 
limb group. These latter defects included: 14.3% of radial aplasia/hypoplasia, 7.9% 
described as upper limb reduction, and 3.2% as polydactyly or pre-axial polydactyly; lobster 
claw hands were described in three (2.4%) sirenomelia cases; postaxial limb reduction, 
webbed upper limbs and upper limb joint contractures, with one case each.
Trunk
Other or unspecified defects of spinal column and of ribs were described in 21.4% of MCA 
cases of sirenomelia. Cardiac defects were present in 20.6% of MCA cases, with 4.8% 
presenting as tetralogy of Fallot, 3.2% as single ventricle, and 2.4% as left heart hypoplasia. 
Defects of central nervous system were described in 19.0% of MCA cases, with spina bifida 
(mainly lower spina bifida) reported in 10.3%, and microcephaly in 2.4% of the cases. 
Esophageal atresia/fistula was described in 12.7% of MCA cases, defects of the diaphragm 
in 3.2% of such cases. In decreasing prevalence order, the following defects were also 
described: omphaloceles (5.6%) and other abdominal wall defects (4.0%). Other cases were 
reported as having abdominal wall defect and ectopia cordis, bladder exstrophy, bladder 
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exstrophy with cephalic celosomia, and gastroschisis (one case for each of these 
associations).
Head
Hydrocephalus was present in 8.7% of MCA cases. Microtia was described in 6.3% of MCA 
cases, and oral clefts in 5.1% of MCA cases. Eye defects were reported in 5.6% of MCA 
cases, with 4.0% being microphthalmia. Several cases (11.9%) had other facial defects, 
including ocular hypertelorism seen in 3.2% of the MCA cases.
Other
Arterial defects different from single or anomalous umbilical artery were described in 9.5% 
of MCA cases, with 4.0% being persistent superior vena cava. Duodenal atresia (4.8%), skin 
tag (2.4%), and holoprosencephaly (one case), were also described among the unrelated 
defects. Since hydrocephalus was frequent and could sometimes be considered as a 
heterotaxic defect, it is important to note that 5.6% of MCA patients presented with other 
heterotaxic defects such as dextrocardia, spleen agenesis or defect, and lung lobation 
anomalies.
Syndromes or Associations
Chromosomal syndromes are not common among the sirenomelia cases. Only 12 cases of 
sirenomelia had karyotype results and all such results were normal. Monogenic syndromes 
were not described in any cases. Considering the association with other VRD there were 
three cases combining sirenomelia and bladder exstrophy, one from Mexico registry and 
two, a twin pair, from South America. Acardia-acephalus were described in two cases with 
sirenomelia, one from Spain [Martínez-Frías, 2009] and one from South America. This last 
case presented also with cyclopia and was a case with acardia-acephalus, cyclopia, and 
sirenomelia. Also from South America there were one case with sirenomelia and conjoined 
twin and other probable case of sirenomelia–cyclopia, described as sirenomelia, medial cleft 
lip, and ocular hypotelorism. Another case from France presented with sirenomelia and 
holoprosencephaly.
DISCUSSION
Prevalence
The sirenomelia prevalence observed in this population of more than 25 million births of 
0.98 per 100,000 births did not differ from previous estimates [Källén et al., 1992; Castilla 
and Orioli, 2004]. The lower prevalence observed in the Hungary registry could reflect some 
under-ascertainment since only 10% of the identified sirenomelias came from ETOPFA, a 
proportion lower than the percentage estimated from the 15 surveillance programs 
registering ETOPFA (49.5%). We observed statistically significant higher sirenomelia 
prevalence in the Mexican, South American, Italy North-East, and Canada Alberta registries, 
and also a lower than expected prevalence in the Italy Campania registry. However, if we 
exclude the data from Hungary and Italy Campania, only the Mexican registry had a higher 
sirenomelia prevalence than the other registries.
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The higher prevalence observed in the Mexican registry has no direct explanation. Other 
registries with limited or no recording of ETOPFA (e.g., South America, Spain, and China) 
did not have a high prevalence of sirenomelia, so lack of ETOPFA does not seem to be a 
likely explanation. The Mexican population could be ethnically different from the other 
studied populations, having a higher proportion of Amerindians [Collins-Schramm et al., 
2004]; however, it is unclear whether this characteristic is likely to account for the higher 
prevalence of sirenomelia. Only specific case–control studies can test this suggestion of an 
association of sirenomelia with ethnicity. A more specific hypothesis is that pre-gestational 
diabetes (e.g., diagnosed and undiagnosed type 2 diabetes), which may be more prevalent in 
the population covered by the Mexican registry than the populations of other registries since 
the prevalence of pre-gestational diabetes is reported to be higher among pregnant Hispanic 
women than among pregnant non-Hispanic white women [Lawrence et al., 2008]. However, 
we did not have adequate data on pre-gestational diabetes in our data to examine the 
possible association of maternal pre-gestational diabetes and sirenomelia.
There is a reasonable level of confidence in the certainty of the sirenomelia diagnosis in the 
249 studied cases. However, unilateral lower limb amelia can sometimes be confounded 
with sirenomelia when the only lower limb has a median position. Since 40 cases (16%) 
were described only by the word sirenomelia, it is possible that diagnostic misclassification 
occurred in a few instances.
Maternal Age
The higher prevalence of sirenomelia observed in the younger maternal age group (less than 
20) is a new finding in the epidemiology of sirenomelia. Since twinning and maternal 
diabetes are usually associated with sirenomelia, and both conditions are more likely to 
occur with older maternal age, the higher prevalence of sirenomelia we found in younger 
mothers was unexpected. Källén et al. [1992] suggested an increased risk of sirenomelia in 
offspring of young and older mothers, but such findings were not statistically significant. 
The higher sirenomelia prevalence we observed in younger mothers was evident in the MCA 
case group but not in the isolated case group. Since there was a similar prevalence gradient 
in the total data set, this lack of significance for the isolated case group could reflect low 
power of small sample sizes or, alternatively, indicate some etiologic difference between the 
isolated and the MCA case groups (e.g., difference in pre-gestational diabetes).
Sex
The sex in sirenomelia was generally based on gonadal or, rarely, on chromosomal 
examination, which explains why almost half of the cases had undetermined sex. However, 
the cases with determined sex did not show a higher prevalence of males as suggested 
previously [Duesterhoeft et al., 2007]. In a small sample of sirenomelia cases (n =32) 
studied by Källén et al. [1992], there were more females than males. However, this 
difference was not statistically different from the expected male-to-female sex ratio.
Other Risk Factors
Due to a lack of systematically collected data on maternal conditions, we were unable to 
confirm previous reports that one-fifth of mothers of sirenomelic infants have diabetes 
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[Gurakan et al., 1996; Martínez-Frías et al., 1998a; Al-Haggar et al., 2010]. Our results, 
however, were more consistent with those of other authors [Stocker and Heifetz, 1987; 
Duncan and Shapiro, 1993; Lynch and Wright, 1997; Duesterhoeft et al., 2007] that reported 
a lower prevalence of maternal diabetes (i.e., less than 4%) among cases of sirenomelia. The 
5% of diabetic mothers in our sample of 133 informative cases coincide with the suggestion 
that diabetes could be a main factor in CRS but not in sirenomelia [Bruce et al., 2009]. This 
does not exclude the possibility that a few cases of sirenomelia may have a pathogenesis 
linked to maternal diabetes that is similar or identical to that of some CRS cases.
Descriptive Analysis
The infants with sirenomelia were born alive in almost half of the cases which did not 
undergo ETOPFA, and presented a higher proportion of prematurity and of twinning than 
expected. These characteristics were the same in both the isolated and MCA case groups.
Associated Defects
The division of infants with sirenomelia into isolated and MCA case groups did not show 
any epidemiological difference between these two groups other than an association with 
younger maternal age in the MCA group. The proportion of each defect considered part of 
the sirenomelia/CRS spectrum was always higher, although not statistically significantly, in 
the MCA than in the isolated group, suggesting that in the former group the cases were 
described in more detail. Since only 16% of patients had the limited descriptor of 
“sirenomelia,” the studied sample of 84% of cases seems appropriate for evaluating the 
extension of the sirenomelia/CRS spectrum.
Single umbilical artery, lethal renal a/dysgenesis, and oligohydramnios, were described 
much more frequently in sirenomelia than in CRS non-sirenomelic [Källén and Winberg, 
1974; Martínez-Frías et al., 2008]. Nonetheless, only the urinary defects, as well as the 
genital, and large bowel defects, were described in approximately half of the cases with 
sirenomelia in our sample. Single or anomalous umbilical artery, as well as defects of the 
lower spinal column, were described in only 16% of the cases, while oligohydramnion 
derived defects in 24.9% of the case. The differences in diagnostic methods (clinical 
examination with or without imaging studies or autopsy) does not explain the observed 
differences of frequency. However, we could not discard that some defects of this spectrum 
with wide phenotypic variability were preferentially described in some registries.
Other defects were described in sirenomelia with a frequency similar to that of the lower 
spinal column defects or single or anomalous umbilical artery frequency. Upper limb 
defects, mainly pre-axial reduction, congenital heart defect, and central nervous system, 
mainly spina bifida, occurred in 14.9%, 10.8%, and 10.4% of all cases, respectively, and 
could be also accepted as part of the sirenomelia/CRS spectrum. Since only cases of 
sirenomelia were studied here, we cannot assess the prevalence of the abovementioned 
defects in non-sirenomelic CRS case-series. Therefore, for future work, the observations 
here reported could only suggest which defects to be included in the sirenomelia spectrum, 
and which considered as associated defects, that is, not as part of the spectrum.
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Several other early defects, such as VATER and twinning, have been linked to 
sirenomelia/CRS through common risk factors such as maternal diabetes [Zaw and Stone, 
2002; Castori et al., 2010] or through the overlapping of the specific defects in each 
condition [Källén and Winberg, 1974]. From the five defects included in the VATER 
acronym (Vertebral, Anal atresia, Tracheo-Esophageal, Renal and Radial anomalies), three 
(VAR) are already part of the accepted sirenomelia/CRS spectrum. Even if we described 
among our sirenomelia cases 28 with radial defects and 16 with tracheo-esophageal 
anomalies, only 3 cases presented exclusively defects of the VATER association. Thus the 
proposition of a unique spectrum for sirenomelia/CRS and VATER [Castori et al., 2010] 
was not supported by our findings.
Some authors [Heifetz, 1984; Stevenson et al., 1986] which support the vascular “steal” 
theory for sirenomelia etiology have proposed that single umbilical artery or anomalous 
umbilical artery were always present in sirenomelia. However, we could not confirm this 
hypothesis with our findings. Because single umbilical artery is considered a minor defect 
and not reported by some registries, the frequency we found could very well represent an 
underestimate. Garrido-Allepuz et al. [2011] have updated the discussion about the two 
hypotheses about sirenomelia etiology, and pointed that both theories were not mutually 
exclusive although the deficient blastogenesis hypothesis explains both the vascular and the 
organs defects.
The frequency of the associations of VRD as those described here, involving sirenomelia 
with bladder exstrophy, holoprosencephaly/cyclopia, or acardia-acephalus in the same infant 
is greater than expected considering the prevalence of each one of these defects. Also the 
association in the same infant of three VRD as sirenomelia, acardia-acephalus, and cyclopia 
is never expected to occur under random expectations. These associations, the high 
frequency of twinning, and the overlap of defects with other early conditions as VATER and 
CRS indicate a common pathway for them. They could be the result of early insults in 
blastogenesis caused by the primary gene mutation or by environmental determinants or by 
interaction of both, and the final phenotype will depend on the disease modifying genes, 
divided in those uniquely affected by the primary mutation, and those whose actions reflect 
generic responses to organism stress evoked by the principal mutation (intermediate 
phenotypes). Since each path involves concatenated networks, the application of biological 
network analysis [Loscalzo et al., 2007], together with molecular results, could help us to 
understand this class of complex diseases.
CONCLUSIONS
Sirenomelia prevalence was noted to be higher in the Mexican registry (2.36 per 100,000) 
than in others registries, with no plausible explanation identified based on the available data. 
Prevalence estimates of sirenomelia around the world were similar otherwise (0.98 per 
100,000), with exception of Hungary and Campania-Italy registries where a low prevalence 
suggests that under-ascertainment could be occurring. The proportion of twinning among 
cases of sirenomelia was higher than the 1 or 2% expected in the general population. The 
sirenomelia prevalence was also higher in younger age mothers among all cases and those 
with MCA, but not among the isolated case. Half of the cases with sirenomelia presented 
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also with genital, large bowel, and urinary defects. About 10–15% of sirenomelia cases had 
lower spinal column defects, single or anomalous umbilical artery, upper limb, cardiac, and 
central nervous system defects. There was a higher than expected association of sirenomelia 
with other VRD such as bladder exstrophy, cyclopia/holoprosencephaly, and acardia-
acephalus. The biological network analysis approach of these related complex conditions 
was suggested for future work.
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Figure 1. 
Total prevalence per 100,000 births (bar) and 95% confidence interval (line) by surveillance 
program and overall (dotted line) of sirenomelia in 19 surveillance programs members of the 
International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR).
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Figure 2. 
Prevalence ratios for maternal age groups relative to the reference age group of 25–29 years 
with corresponding 95% confidence intervals for sirenomelia in 19 surveillance program 
members of the International Clearinghouse for Birth Defects Surveillance and Research 
(ICBDSR).
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